These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30411083)

  • 1. Gamma Glutamyltransferase Reduction Is Associated With Favorable Outcomes in Pediatric Primary Sclerosing Cholangitis.
    Deneau MR; Mack C; Abdou R; Amin M; Amir A; Auth M; Bazerbachi F; Marie Broderick A; Chan A; DiGuglielmo M; El-Matary W; El-Youssef M; Ferrari F; Furuya KN; Gottrand F; Gupta N; Homan M; Jensen MK; Kamath BM; Mo Kim K; Kolho KL; Konidari A; Koot B; Iorio R; Martinez M; Mohan P; Palle S; Papadopoulou A; Ricciuto A; Saubermann L; Sathya P; Shteyer E; Smolka V; Tanaka A; Valentino PL; Varier R; Venkat V; Vitola B; Vos MB; Woynarowski M; Yap J; Miloh T
    Hepatol Commun; 2018 Nov; 2(11):1369-1378. PubMed ID: 30411083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis: Predictors of Gamma Glutamyltransferase Normalization and Favorable Clinical Course.
    Deneau M; Perito E; Ricciuto A; Gupta N; Kamath BM; Palle S; Vitola B; Smolka V; Ferrari F; Amir AZ; Miloh T; Papadopoulou A; Mohan P; Mack C; Kolho KL; Iorio R; El-Matary W; Venkat V; Chan A; Saubermann L; Valentino PL; Shah U; Miethke A; Lin H; Jensen MK
    J Pediatr; 2019 Jun; 209():92-96.e1. PubMed ID: 30878206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Prospective Trial of Withdrawal and Reinstitution of Ursodeoxycholic Acid in Pediatric Primary Sclerosing Cholangitis.
    Black DD; Mack C; Kerkar N; Miloh T; Sundaram SS; Anand R; Gupta A; Alonso E; Arnon R; Bulut P; Karpen S; Lin CH; Rosenthal P; Ryan M; Squires RH; Valentino P; Elsea SH; Shneider BL
    Hepatol Commun; 2019 Nov; 3(11):1482-1495. PubMed ID: 31701072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral Vancomycin, Ursodeoxycholic Acid, or No Therapy for Pediatric Primary Sclerosing Cholangitis: A Matched Analysis.
    Deneau MR; Mack C; Mogul D; Perito ER; Valentino PL; Amir AZ; DiGuglielmo M; Draijer LG; El-Matary W; Furuya KN; Gupta N; Hochberg JT; Horslen S; Jensen MK; Jonas MM; Kerkar N; Koot BGP; Laborda TJ; Lee CK; Loomes KM; Martinez M; Miethke A; Miloh T; Mohammad S; Ovchinsky N; Rao G; Ricciuto A; Sathya P; Schwarz KB; Shah U; Singh R; Vitola B; Zizzo A; Guthery SL
    Hepatology; 2021 Mar; 73(3):1061-1073. PubMed ID: 32946600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The natural history of primary sclerosing cholangitis in 781 children: A multicenter, international collaboration.
    Deneau MR; El-Matary W; Valentino PL; Abdou R; Alqoaer K; Amin M; Amir AZ; Auth M; Bazerbachi F; Broderick A; Chan A; Cotter J; Doan S; El-Youssef M; Ferrari F; Furuya KN; Gottrand M; Gottrand F; Gupta N; Homan M; Kamath BM; Kim KM; Kolho KL; Konidari A; Koot B; Iorio R; Ledder O; Mack C; Martinez M; Miloh T; Mohan P; O'Cathain N; Papadopoulou A; Ricciuto A; Saubermann L; Sathya P; Shteyer E; Smolka V; Tanaka A; Varier R; Venkat V; Vitola B; Vos MB; Woynarowski M; Yap J; Jensen MK
    Hepatology; 2017 Aug; 66(2):518-527. PubMed ID: 28390159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gamma-glutamyl transferase and disease course in pediatric-onset primary sclerosing cholangitis: A single-center cohort study.
    Berhane B; van Rheenen PF; Verkade HJ
    Health Sci Rep; 2023 Feb; 6(2):e1086. PubMed ID: 36751275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of Primary Sclerosing Cholangitis Beyond Childhood is Associated with Worse Outcomes.
    Tica S; Alghamdi S; Tait C; Nemera B; Turmelle Y; Fleckenstein J; Stoll J; Kulkarni S
    J Clin Exp Hepatol; 2022; 12(1):110-117. PubMed ID: 35068791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single or multiple dose ursodeoxycholic acid for cholestatic liver disease: biliary enrichment and biochemical response.
    van de Meeberg PC; Wolfhagen FH; Van Berge-Henegouwen GP; Salemans JM; Tangerman A; van Buuren HR; van Hattum J; van Erpecum KJ
    J Hepatol; 1996 Dec; 25(6):887-94. PubMed ID: 9007717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis.
    Mitchell SA; Bansi DS; Hunt N; Von Bergmann K; Fleming KA; Chapman RW
    Gastroenterology; 2001 Oct; 121(4):900-7. PubMed ID: 11606503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between reduced levels of alkaline phosphatase and survival times of patients with primary sclerosing cholangitis.
    Lindström L; Hultcrantz R; Boberg KM; Friis-Liby I; Bergquist A
    Clin Gastroenterol Hepatol; 2013 Jul; 11(7):841-6. PubMed ID: 23353641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and clinical course of primary sclerosing cholangitis in France: a prospective cohort study.
    Garioud A; Seksik P; Chrétien Y; Corphechot C; Poupon R; Poupon RE; Chazouillères O
    Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):842-7. PubMed ID: 19779305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alkaline phosphatase at diagnosis of primary sclerosing cholangitis and 1 year later: evaluation of prognostic value.
    de Vries EM; Wang J; Leeflang MM; Boonstra K; Weersma RK; Beuers UH; Geskus RB; Ponsioen CY
    Liver Int; 2016 Dec; 36(12):1867-1875. PubMed ID: 26945698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of ursodeoxycholic acid in the treatment of primary sclerosing cholangitis in children.
    Gilger MA; Gann ME; Opekun AR; Gleason WA
    J Pediatr Gastroenterol Nutr; 2000 Aug; 31(2):136-41. PubMed ID: 10941964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis.
    Fickert P; Hirschfield GM; Denk G; Marschall HU; Altorjay I; Färkkilä M; Schramm C; Spengler U; Chapman R; Bergquist A; Schrumpf E; Nevens F; Trivedi P; Reiter FP; Tornai I; Halilbasic E; Greinwald R; Pröls M; Manns MP; Trauner M;
    J Hepatol; 2017 Sep; 67(3):549-558. PubMed ID: 28529147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver disease associated with ZZ alpha1-antitrypsin deficiency and ursodeoxycholic acid therapy in children.
    Lykavieris P; Ducot B; Lachaux A; Dabadie A; Broué P; Sarles J; Bernard O; Jacquemin E
    J Pediatr Gastroenterol Nutr; 2008 Nov; 47(5):623-9. PubMed ID: 18955864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Natural History of Primary Sclerosing Cholangitis in Children: A Large Single-Center Longitudinal Cohort Study.
    Valentino PL; Wiggins S; Harney S; Raza R; Lee CK; Jonas MM
    J Pediatr Gastroenterol Nutr; 2016 Dec; 63(6):603-609. PubMed ID: 27504812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory Bowel Disease in Children with Elevated Serum Gamma Glutamyltransferase Levels.
    Chandrakumar A; Loeppky R; Deneau M; El-Matary W
    J Pediatr; 2019 Dec; 215():144-151.e3. PubMed ID: 31500861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: a randomized placebo-controlled trial.
    Färkkilä M; Karvonen AL; Nurmi H; Nuutinen H; Taavitsainen M; Pikkarainen P; Kärkkäinen P
    Hepatology; 2004 Dec; 40(6):1379-86. PubMed ID: 15565569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of inflammatory bowel disease and ursodeoxycholic acid therapy on small-duct primary sclerosing cholangitis.
    Charatcharoenwitthaya P; Angulo P; Enders FB; Lindor KD
    Hepatology; 2008 Jan; 47(1):133-42. PubMed ID: 17992695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary sclerosing cholangitis response to the combination of fibrates with ursodeoxycholic acid: French-Spanish experience.
    Lemoinne S; Pares A; Reig A; Ben Belkacem K; Kemgang Fankem AD; Gaouar F; Poupon R; Housset C; Corpechot C; Chazouillères O
    Clin Res Hepatol Gastroenterol; 2018 Dec; 42(6):521-528. PubMed ID: 30100231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.